Rutgers and RWJBarnabas Plan Cancer Pavilion

Published 2-23-2020
  • Rutgers Cancer Institute of New Jersey & RWJBarnabas Health – Cancer Pavilion
  • Rutgers Cancer Institute of New Jersey & RWJBarnabas Health – Cancer Pavilion
  • Rutgers Cancer Institute of New Jersey & RWJBarnabas Health – Cancer Pavilion
  • Rutgers Cancer Institute of New Jersey & RWJBarnabas Health – Cancer Pavilion

    Courtesy of DEVCO.

  • Rutgers Cancer Institute of New Jersey & RWJBarnabas Health – Cancer Pavilion

    Courtesy of DEVCO.

  • Rutgers Cancer Institute of New Jersey & RWJBarnabas Health – Cancer Pavilion

    Courtesy of RWJBarnabas Health.

Rutgers Cancer Institute of New Jersey and RWJBarnabas Health are planning to break ground in fall of 2020 on the $750 million Cancer Pavilion in New Brunswick. Created in partnership with the New Brunswick Development Corporation (DEVCO), the 12-story, 510,000-sf structure will enable the consolidation of key cancer services in a single integrated location. Collocating research and clinical functions, the translational facility will provide an outpatient area with 84 infusion bays, 74 exams rooms, a diagnostic imaging suite, core labs, an urgent care center, a pharmacy, and an advanced radiology center with four linear accelerators. Inpatient amenities will include 96 beds on three floors, a dedicated floor for surgeries and procedures, and a central sterile processing area. The pavilion will also accommodate wet labs and support spaces for 10 research teams, as well as faculty and clinical trial offices. HOK is the architect for the project, which is slated for completion in late 2023.

Related Organizations